You are here

2013

Genome Canada Applauds Throne Speech

Friday, October 18, 2013

Genome Canada applauds the federal government’s Speech from the Throne, commending the government’s pledge to protect and promote traditional resource sectors.

Research Catalyst Network: Rare Diseases

Thursday, October 17, 2013

The goal of the “Research Catalyst Network: Expediting collaboration between basic and clinician scientists in functional studies of novel rare disease genes” is to establish a national consortium that will enable clinical geneticists who are identifying rare disease gene mutations to collaborate with model organism researchers with expertise in the cognate gene’s function.

Capitalizing On Big Data: Agencies launch consultation on digital scholarship

Wednesday, October 16, 2013

Canada’s federal research granting agencies—the Social Sciences and Humanities Research Council (SSHRC), the Natural Sciences and Engineering Research Council (NSERC), the Canadian Institutes of Health Research (CIHR), as well as the Canada Foundation for Innovation (CFI), and in collaboration with Genome Canada—have joined forces to help address digital infrastructure challenges through the consultation document 

New Discoveries for Cancer Risk: Researchers Worldwide Take Part in one of History’s Largest Scientific Consortium

Wednesday, October 9, 2013

Hundreds of researchers from North America, Europe, Australia and Asia have joined together in a consortium to identify the genetic basis of the five most common forms of cancer – breast, prostate, lung, ovarian and colorectal. The group, called the OncoArray Consortium, developed a new customized genotyping tool – the OncoArray – manufactured by the U.S. genomics firm Illumina, Inc.

Ontario Genomics Institute Launches Scintelligence, a New Division to Help Industry Tap into the Power of Life Science Solutions

Tuesday, September 24, 2013

The Ontario Genomics Institute (OGI) today announced the launch of Scintelligence, a new industry-focused division to help companies in a variety of sectors capitalize on research and innovation in the life sciences. This division will engage the private sector to identify challenges and business needs, and facilitate collaborations between partners in industry, academia and government.

Vancouver Researchers Moving Forward on Eliminating HIV/AIDS

Wednesday, September 18, 2013

In 1988, Walter Hiebert was given what amounted to a death sentence: he was diagnosed with HIV and given just six months to live. “I didn’t have any hope at all,” says 56 year-old Hiebert, who had to go on disability from his job as a registered nurse.

Official launch of the new IPAC Resource

Thursday, September 12, 2013

Since the sequence map of the human genome, the cost of sequencing the genome of an individual has fallen rapidly. This has resulted in a tremendous increase in the amount of human genomic data available to the international research community for the advancement of biomedical research. Yet, there is an absence of international mechanisms to support researchers in ensuring ethical and legal interoperability.

Message from Genome Canada on the passing of Dr. Anthony Pawson

Monday, August 12, 2013

It is with deep regret that Genome Canada has learned of the recent passing of Dr. Anthony Pawson. Dr. Pawson was truly a star in Canadian genomics research. His contributions to the scientific community and humanity earned him international renown, including the prestigious Kyoto Prize in 2008. In particular, he was recognized for his influential work on how human cells communicate with one another.

Funding Awarded to Detect E.Coli in Food Processing Facilities

Saturday, June 15, 2013

Media Release, Calgary - Genome Alberta is pleased to announce on behalf of our funding partners the Alberta Livestock and Meat Agency, Alberta Innovates Bio Solutions, Genome Canada, Genome Quebec, and the Ontario Ministry of Agriculture and Food and the Ministry of Rural Affairs, the results of our collective funding competition for the  rapid detection of pathogenic E.coli. Each of the two successful applications will receive $500,000 in new funding.

Pages